Live Markets
Wednesday, July 29, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Basic Materials

Kraig Biocraft Laboratories, Inc. (KBLB)

OQB · Specialty Chemicals

$0.10+0.01 (+6.80%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$110.2M
P/E (TTM)
Infinity
EPS
—
Div Yield
—
52W Range
$0.07–$0.16
Beta
1.52

Company overview

Kraig Biocraft Laboratories, Inc. develops protein-based fibers using recombinant DNA technology for commercial applications in the textile and specialty fiber industries in the United States. The company's primary proprietary fiber technology includes natural and engineered variants of spider silk produced in domesticated mulberry silkworms, as well as uses genetically engineered silkworms that produce spider silk proteins to create its recombinant spider silk. Its products are used in performance apparel, workwear, filtration, luxury fashion, flexible composites, medical implants, cosmetics, and other applications; and military and police for its ballistic protection. Kraig Biocraft Laboratories, Inc. was incorporated in 2006 and is headquartered in Ann Arbor, Michigan.

37 employeeswww.kraiglabs.com

Peers in Basic Materials

Kraig Biocraft Laboratories, Inc. has no peer companies in this window.

Recent press releases

April 2026

3 months agoPOS AM

KBLB amends IPO filing amid zero revenue and going concern warnings

KBLBKraig Biocraft Laboratories, Inc.

# 📜 What This Document Is 📰 This document is a Post-Effective Amendment No. 3 to a Form S-1 Registration Statement. In simple terms, an S-1 is what a company files with the SEC when it is preparing to sell its stock to the public (an Initial Public Offering, or IPO). This amendment means the comp

Read summaryView on SEC EDGAR
1 recent filing shown in the timeline above. View all SEC filings →

Kraig Biocraft Laboratories, Inc. has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
50,000 sh0.0%

People at Kraig Biocraft Laboratories, Inc.

All people →

Quarterly financials

Full financials →
Revenue trend
03/25
—
NI -$600.0K
06/25
—
NI -$726.1K
09/25
—
NI -$1.5M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $0.00
Prior: $0.00
Revenue sparkline
KBLB (OQB) Stock Quote, Press Releases & SEC... | Cayman Journal | Cayman Journal